News in the Life Sciences Industry

DUBLIN, Nov. 5, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quarter of 2019 and updated 2019 financial guidance.

INCHINNAN, Scotland, Nov. 5, 2019 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today announced that it is investing nearly $24 million in its Inchinnan, Scotland, site to expand global bioproduction capabilities with additional large-volume liquid manufacturing... Read more ››

Strategic investments support efforts to bring advanced medicines to market faster

EXTON, Pa., Nov. 5, 2019 /PRNewswire/ -- (Booth #111F62)--West Pharmaceutical Services, Inc. (NYSE: WST), a global... Read more ››

SEOUL, South Korea, Nov. 5, 2019 /PRNewswire/ -- Janssen Korea Ltd. and Johnson & Johnson Innovation LLC, in collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute (KHIDI), today announced the awardees of the Read more ››

SHANGHAI, Nov. 4, 2019 /PRNewswire/ -- LY03004, Luye Pharma's innovative, independently developed Extended-Release Microspheres for Injection has taken another step closer to going on the U.S. market. The company has announced that it has received the Establishment Inspection Report from the... Read more ››

PALM BEACH GARDENS, Fla., Nov. 4, 2019 /PRNewswire/ -- Seoul National University Bundang Hospital (SNUBH) (https://www.snubh.org/dh/en/)... Read more ››

- Alliance to focus combined expertise and investment to maximise Jardiance® for people with type 2 diabetes, heart failure, and chronic kidney disease

Regulatory filing is a major step toward commercialization of transfusion-medicine innovation

Forthcoming Category lll CPT Code Reflects the Published Clinical Evidence and
A Determination of Significant Value of Real-Time Fluorescence Imaging
Across the Wound Care Treatment Pathway

SINGAPORE, Nov. 4, 2019 /PRNewswire/ -- Commissioned by Novartis Oncology, The Count Us, Know Us, Join Us Advanced Breast Cancer (ABC) survey today unveils valuable insights that put a spotlight on patients' perspectives as we conclude Breast Cancer Awareness Month. The survey, which was set... Read more ››

BURGWEDEL, Germany, Nov. 1, 2019 /PRNewswire/ -- MYR Pharmaceuticals today announced the presentation of a number of results on bulevirtide at the upcoming meeting of American Association for the Study of Liver Diseases (AASLD), in Boston, US.

KEMPTEN, Germany, Nov. 1, 2019 /PRNewswire/ -- Following Frankfurt, Mumbai, and Hyderabad, Atlanta is now Dachser's fourth location to receive certification in ten months, further expanding the company's network services for its customers in the life science and healthcare sector.

25th-26th November 2019, Berlin